15/08/2025
Have your say. It's time Pharmac looked at the big picture and it's not all about medication but prevention
It is with a heavy heart that I share this latest information about funding micronutrients in NZ. I haven't posted in a while on this topic as I have made no progress on changing the current impasse preventing easy access to micronutrients in NZ. It isn't because I and others haven't been writing, calling or visiting with those who could change this situation (employees of Ministry of Health, MPs etc).
While perhaps some are sympathetic, the system is too medically orientated to allow a non-medicine to be funded like a medicine.
The latest development is that the funding application I made in 2022 (and supported by hundreds of letters from the public) where Pharmac agreed Daily Essential Nutrients (DEN) should be considered as a second line form of treatment for ADHD but designated it as a low priority for funding, are now wanting to remove it from their list and decline it on the basis that "no company is willing to supply the medicine in New Zealand".
This is not true. Hardy Nutritionals is willing to apply to make DEN a medicine but medsafe won't accept their current GMP registered site of manufacturing. In other words, medsafe will only accept a pharmaceutical grade facility as being acceptable. This is not an option for the company to move their manufacturing at this time.
What can you do as a consumer or member of the public? I always think that change will happen from the grassroots. You can email: applicationfeedback@pharmac.govt.nz by 5pm on Tuesday 9 September 2025 if you have a reason why Pharmac should not progress declining the application for DEN to be funded.
There is no big company pushing Pharmac to fund this treatment.
There are simply those who have benefitted who could write and perhaps reverse this decision. Please help. Please write, please let Pharmac know what you think of this latest development trying to keep supplements away from being funded by tax payers.
This application isnât being declined because DEN isnât efficacious or there is evidence that it is harmful. It is being declined because it doesnât fit into the pharma model.
Why is there so much resistance to change the status quo and to find a way forward rather than find reasons why nothing should be changed? After so many emails, letters, meetings and correspondence, never once has anyone said, letâs find a way to fix this problem.
I am sorry I can't share better news. Please share widely.
https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/2025-08-proposal-to-decline-inactive-applications
Image created with help from co-pilot